Medicaid Drug Rebate Agreements: Changes Require Immediate Action By Pharmaceutical Manufacturers
For the first time since the enactment of the Medicaid Drug Rebate Program (MDRP), the Centers for Medicare and Medicaid Services (CMS) revised the National Medicaid Drug Rebate Agreement (NDRA) entered into between drug manufacturers and the U.S. Department of Health and Human Services (HHS). Drug manufacturers with existing active NDRAs now have until September…… Continue reading this entry